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Abstract
Introduction In the Netherlands, the number of bariatric procedures increased exponentially in the 90s. To ensure and improve
the quality of bariatric surgery, the nationwide Dutch Audit for Treatment of Obesity (DATO) was established in 2014. The audit
was coordinated by the Dutch Institute for Clinical Auditing (DICA). This article provides a review of the aforementioned
process in establishing a nationwide registry in the Netherlands.
Materials and Methods In collaboration with the DATO’s scientific committee and other stakeholders, an annual list of several
external quality indicators was formulated. This list consists of volume, process, and outcome indicators.
In addition to the annual external indicators, the database permits individual hospitals to analyze their own data. The dash-
board provides several standardized reports and detailed quality indicators, which are updated on a weekly base.
Results Since the start, all 18 Dutch bariatric centers participated in the nationwide audit. A total of 21,941 cases were registered
between 2015 and 2016. By 2016, the required variables were registered in 94.3% of all cases. A severe complicated course was
seen in 2.87%, and mortality in 0.05% in 2016. The first-year follow-up shows a > 20% TWL in 86.1% of the registered cases.
Discussion The DATO has become rapidly a mature registry. The well-organized structure of the national audit institution DICA
and governmental funding were essential. However, most important were the bariatric teams themselves. The authors believe
reporting the results from the registry has already contributed to more knowledge and acceptance by other health care providers.
This manuscript was written on behalf of the Dutch Audit for Treatment
of Obesity (DATO) Group: E.J. Hazebroek, MD, PhD (Rijnstate
Hospital, Arnhem); L.M. de Brauw, MD, PhD (MC Slotervaart,
Amsterdam); A. Demirkiran, MD, PhD (Red Cross Hospital,
Beverwijk); M. Dunkelgrün, MD, PhD (Franciscus Gasthuis &
Vlietland, Rotterdam); I.F. Faneyte, MD, PhD (ZGT Hospital,
Hengelo); J.W.M. Greve, MD, PhD (Zuyderland MC, Heerlen); M.J.
Wiezer, MD, PhD (St. Antonius Hospital, Nieuwegein); E.H. Jutte, MD
(MC Leeuwarden, Leeuwarden); R.A. Klaassen, MD (Maasstad
Hospital, Rotterdam); E.A.G.L. Lagae, MD (ZorgSaam Zorggroep
Zeeuws-Vlaanderen, Terneuzen); B. Lamme, MD, PhD (Albert
Schweitzer Hospital, Dordrecht); R.S.L. Liem, MD (Groene Hart
Hospital, Gouda); J.K. Maring, MD, PhD (Elisabeth-TweeSteden
Hospital, Tilburg); S.W. Nienhuijs, MD, PhD (Catharina Hospital,
Eindhoven); R. Schouten, MD, PhD (MC Zuiderzee, Lelystad); D.J.
Swank, MD, PhD (Dutch Obesity Clinic West, The Hague); G. van ‘t
Hof, MD (Dutch Obesity Clinic South-West Netherlands, Bergen op
Zoom); R.N. van Veen, MD, PhD (OLVG Hospital, Amsterdam); and
M.W.J.M. Wouters, MD, PhD (Netherlands Cancer Institute-Antoni van
Leeuwenhoek Hospital, Amsterdam).
* Youri Q.M. Poelemeijer
Y.Q.M.Poelemeijer@lumc.nl
1 Dutch Institute for Clinical Auditing, Scientific Bureau,
Leiden, Netherlands
2 Department of Surgery, Leiden University Medical Center,
Albinusdreef 2, 2333 ZA Leiden, Netherlands
3 Department of Surgery, Groene Hart Hospital, Gouda, Netherlands
4 Department of Surgery, Catharina Hospital, Eindhoven, Netherlands
Obesity Surgery
https://doi.org/10.1007/s11695-017-3062-2
Keywords Clinical auditing . Registry . Nationwide . Bariatric surgery . Netherlands . DATO . Dutch Audit for Treatment of
Obesity . DICA . Dutch Institute for Clinical Auditing . Obesity
Introduction
Bariatric surgery has already been proven as the only long-
term effective treatment option for morbid obesity in terms of
weight loss and comorbidities reduction [1–4]. Although this
effect is nowadays embedded in several guidelines and accept-
ed by most practitioners, still some resistance exists [5, 6].
Especially for bariatric surgery, showing outcome transparent-
ly by clinical auditing is of utmost importance [7]. This should
not only consist of the clinical outcomes, but also process
indicators and patient-reported outcomes should be included
as well [8, 9]. For this purpose, a registry was necessary for
structured evaluation of bariatric surgical care.
History
In the Netherlands, the number of bariatric procedures in-
creased exponentially in the 90s [10]. To deal with this in-
crease, various health insurers started to keep track of their
own individual quality indicators. The result was a fragmented
and incomparable list of outcomes between various healthcare
providers.
In order to define comparable outcomes, healthcare profes-
sionals took the initiative themselves. In 1996, the bariatric
institutions of Belgium, the Netherlands, and Luxembourg
united into the BeNeLux Association of Bariatric Surgeons
(BABS). This was an improvement for scientific research.
However, for the improvement of quality in healthcare, the
differences between countries seemed to be a burden.
This led to the formation of a national working group for
bariatric surgeons in the Netherlands, initiated by the Dutch
Society for Gastrointestinal Surgery (DSGS), which was a
subsidiary association of the Association of Surgeons of the
Netherlands (ASN). This working group continued in April
2011 as the Dutch Society for Metabolic and Bariatric Surgery
(DSMBS) and is now also the official national chapter of the
International Federation for the Surgery of Obesity and
Metabolic Disorders (IFSO).
Registries
At the end of the 90s, only a few local initiatives were
launched echoing various European registries. A commonly
used system in the early 2000’s was the Patients Outcome
Measurement Tool (POMT), originally co-funded by a medi-
cal device supplier. Some users regarded the interference of
industry as a restriction, others experienced some technical
drawbacks. Due to the large input of international
incomparable data, the results were difficult to interpret for
each individual hospital.
Most bariatric centers, not using POMT, had their own
hospital ICT system or used Microsoft Excel as a database
management system. Derived from POMTor homemade sys-
tems, data could be used for iBAR (international BAriatric
Registry). This European registry was launched in 2008 by
the European Accreditation Council for Bariatric Surgery
(EAC-BS). The aim of this registry was the creation of guide-
lines that could be applied to different global areas and define
surgeon’s credentials and institutional requirements for safe
and efficient management of morbidly obese patients. The
implementation of these guidelines would be applied by
IFSO regional chapters in collaboration with the national bar-
iatric and metabolic societies. In Europe, Middle East, and
Africa, the IFSO European Chapter (IFSO-EC) was autho-
rized to approve these BCenters of Excellence^ (COE) in col-
laboration with the European Accreditation Council for
Bariatric Surgery (EAC-BS).
Despite the promising start, the international data were too
difficult to interpret and comparison between countries was
complicated by European laws. In addition, the mandatory set
contained too many variables. Due to this large number of
variables, there was an insufficient focus on the processes
and outcomes of the delivered care. Therefore, this registry
was not suitable for a nationwide mandatory registry (Fig. 1).
DICA
A successful Dutch example of clinical auditing was the
Dutch Surgical Colorectal Audit (DSCA), born from the de-
mand for national quality registries in the surgical field [11].
From this initiative, the Dutch Institute for Clinical Auditing
(DICA) was founded in 2009. DICA now has 23 national
registries, which facilitates clinical audits for 15 surgical and
non-surgical societies. DICA consists of a directional board,
management board, methodological board providing supervi-
sion of applied methodology, privacy committee providing
supervision on privacy issues, and a scientific bureau facilitat-
ing a sound board for the registries (Fig. 2).
Aim
The aim of this manuscript was to provide a review of the
aforementioned process in establishing a nationwide registry
in the Netherlands, with the Dutch Audit of Treatment of
Obesity (DATO) as a result.
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Methods
Funding
One of the important goals of the DSMBS was to establish a
nationwide registry. In 2012, the DSMBS announced the start
of a new nationwide mandatory registry. The funding arose
from a special quality improvement grant from the umbrella
organization of nine health insurers in the Netherlands, called
BZorgverzekeraars Nederland^ (ZN). ZN offered a financial
structure to establish and maintain this nationwide audit. In
cooperation with DICA, the Dutch Audit for Treatment of
Obesity (DATO) was established in 2014. Structural funding
is currently provided by the same umbrella organization. The
audit has officially started on January 1, 2015.
Scientific Committee
A scientific committee and a clinical audit board (CAB) was
put in charge of overseeing its long-term goals and monitoring
the quality of the registry.
The scientific committee represents all 18 bariatric centers
and all members are mandated from the practicing hospital
where they are employed. As a result, all practicing hospitals
have an influence on the decision making within the scientific
committee. In addition, the scientific committee has the task of
assessing the quality and feasibility of (international) scientific
applications.
The scientific committee provides three mandated deputies
for the CAB. The CAB consists of a chairman, a secretary, and
a treasurer and is responsible for day-to-day running of the
registry. Any decision taken by the CAB must be officially
reported to the scientific committee.
Patient Selection
The nationwide database covers all bariatric procedures in the
Netherlands. The inclusion criteria for primary bariatric sur-
gery in the Netherlands are linked to stringent requirements
which are bundled in the Dutch Morbid Obesity Directive
[12]. These inclusion criteria were defined by international
literature and expert opinions [4, 13, 14].
Patients must be 18 years or older and must be sufficiently
healthy to undergo general anesthesia and surgery. In addition,
theymust have a bodymass index (BMI) of ≥ 40.0 kg/m2, or a
BMI ≥ 35.0 kg/m2 in combination with at least one of the 6
major obese-related comorbidities: diabetesmellitus [1, 2, 15],
hypertension [1, 15], dyslipidemia [15], obstructive sleep ap-
nea syndrome (OSAS) [16], gastroesophageal reflux disease
(GERD) [17], and musculoskeletal pain [18]. Weight loss as a
result of intensive treatment prior to surgery (in patients who
reached a weight below the minimum BMI indication for sur-
gery) is not a contraindication for planned bariatric surgery.
Bariatric surgery is contraindicated if patients suffer from
severe psychological problems, been addicted to alcohol [19],
drugs [20] or other substances, an active gastrointestinal dis-
ease, or a disease that is life threatening on short terms.
Registration
The surgical department is primarily responsible for all the
data entry. Some hospitals decided to transfer the responsibil-
ity of screening and follow-up data to other institutions like
Fig. 1 A timeline about the DATO’s origin
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the Dutch Obesity Clinics (NOK). An overview of parameters
recorded in DATO was given in Table 1.
For identification of unique patients, social security num-
ber, surname, date of birth, and sex are mandatory and regis-
tered. This patient’s traceable data is anonymized by a data
processing company before analyzes taken place. Therefore,
all data is anonymous for people outside the hospital.
Screening
The registration of the pre-operative comorbidities occurs when
the specific condition is present on the day of screening.
Comorbidity is thus given in the registry as a yes/no option. To
predict the postoperative mortality, the Charlson Comorbidity
Index (CCI) is registered [21, 22]. As for diabetes mellitus, hy-
pertension, dyslipidemia, GERD, and OSAS, a few sub-items
are registered like the use of medication and laboratory tests.
To chart the surgical history, 10 main surgical areas are
specified: surgical interventions of hernias, stomach, duode-
num, liver, biliary tract, pancreas, small intestine, appendix,
colon, and rectum. In addition, a second item registers which
bariatric procedure has taken place in the past.
Procedure and Follow-up
Registration of the operation date and type of procedure with
corresponding details is mandatory. A maximum of 5
procedure-specific items are requested per procedure.
Complications are scored using the Clavien-Dindo
Classification of Surgical Complications (CDC) [23].
The follow-up consists of postoperative weight registra-
tion, monitoring of pre-operative registered comorbidities,
and any (long-term) complications (Table 1). The follow-up
will be recorded at 3, 6, 9, 12, 24, 36, 48, and 60 months,
Fig. 2 Organisational structure of the Dutch Institute for Clinical Auditing (DICA)
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depending on the hospital and the applicable protocol. Each
patient must be seen at least once a year (Table 2).
RAND-36
Patient-reported outcomes (PROs) are measured with the
RAND 36-item Health Survey (RAND-36). The RAND-36
has been developed within the framework of the RAND
Health Science Program in the USA. The questionnaire is
identical to the MOS SF-36 questionnaire, but contains anoth-
er scoring algorithm. The RAND-36 measures 8 health do-
mains: physical functioning, role limitations caused by phys-
ical health problems, and role limitations caused by emotional
problems, social functioning, emotional well-being, vitality,
pain, and general health perception [24–26].
Data Entry
There are two methods to provide the required data for DATO.
The first method is by a so-called batch file, where the hospital
itself extracts the necessary data from its own electronic health
records software. A second option uses a secure web-based reg-
istration interface, offered by DICA. The PROs are measured in
a separate database and can be cross-matched with the clinical
database.
Data Quality
To increase data quality, a clear definition is set for
each data entry point with an additional explanation
mark. If impracticable values or the data yields outside
its predefined range, an error message occurs. A second
safety measure is an automatic generated alert list, with
a list of all incomplete mandatory variables for each
patient record.
Once every 2 years, DICA facilitates monitoring of data
quality by an external organization. Trained personnel ran-
domly verify hospital data entered in DATO with their own
electronic patient records. The results of all randomly chosen
hospitals are discussed and assessed by an external quality
Table 1 Variables recorded in
DATO Section (dataset) Variable Baseline Follow-up
Patient characteristics Social security number M –
Date of birth M –
Sex M –
Alive/dead status M M
Screening Weight M M
Highest weight R –
Length M –
Hypertension M M
Diabetes mellitus M M
Dyslipidemia M M
GERD M M
OSAS M M
Musculoskeletal pain M M
Charlson Comorbidity Index R –
Abdominal history If yes—8 sub-items could be answereda R –
Bariatric history If yes—5 sub-items could be answeredb R –
Procedure Date of operation M –
Name/code of surgeon R –
ASA score M –
Type of surgical procedure M –
Clavien-Dindo Classification of Surgical Complications M –
Follow-up Evaluation comorbidities – M
Complications during previous periodc – M
PROMs RAND-36 M M
ASA American Society of Anesthesiologists, M mandatory, R recommended
a Surgical interventions of hernias, stomach, duodenum, liver, biliary tract, pancreas, small intestine, appendix,
colon, and/or rectum by laparoscopy or laparotomy
bYear of operation, type of surgery, type of technique, and/or hospital
c As defined by Clavien-Dindo Classification of Surgical Complications
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committee. The results and recommendations will eventually
be presented in an online accessible report.
Quality Indicators
In collaboration with the DATO’s scientific committee, pro-
fessional societies, hospital organizations, Dutch Patient
Federation (DPF), and the health insurance companies, an
annual list of external quality indicators is formulated.
Indicators were derived from the international literature or
written on a consensus-based development process within
the scientific committee. The list is annually approved and
accredited by various stakeholders. In relation to quantity
and quality, the minimum volume was set by DSMBS at
100 procedures per individual hospital in 2015 and 2016.
To analyze the different aspects of the surgical process,
there are three types of quality indicators. The structure indi-
cator provides information about the amount of bariatric pro-
cedures. The process indicators provide information about the
completeness of registered (mandatory) variables to calculate
all other indicators, correctness of the individual indication for
bariatric surgery, and the lost to follow-up. The outcome indi-
cators focus on clinical outcomes after bariatric surgery and
possible surgical and non-surgical complications.
The lost to-follow-up indicator provides insight into the
number of patients who are no longer visiting the outpatient
clinic in their own hospital. The registration year for indicators
with follow-up data runs from September to September. In
these cases, there are no patients wrongly considered missing
when their appointment falls within 12 to 14.5 months after
the primary surgery date. This also applies to the indicator
excess weight loss (EWL) and total weight loss (TWL).
Excess weight loss (EWL) is calculated using the formula
initial weight−postoperative weight
initial weight−α , with reference point α as an ideal
BMI of 25 kg/m2. Total weight loss (TWL) is calculated with
the formula initial weight−postoperative weightinitial weight [5, 27].
Benchmark
The database permits individual hospitals to analyze their own
data. The dashboard provides several standardized reports and
detailed quality indicators, which are updated on a weekly
basis in a secured web-based environment, called myDATO.
Participating hospitals recognize their own results in these
funnel plots from a highlighted dot. The results of any other
hospital are shown with an anonymous gray dot (Fig. 3).
Table 2 Annual quality indicator
DATO report Number Indicator 2015 2016
N D % N D %
Process
2 Percentage of complete registered patient
records regarding primary and/or
secondary surgery.
9534 10,355 92.1 10,922 11,586 94.3
3 Percentage of primary operated patients,
meeting the inclusion criteria on the
basis of BMI and age.
8371 8756 95.6 9625 10,028 96.0
4 Percentage of primary operated patients,
who are lost to follow-up in the first year
after primary surgery.
– – – 131 6433 2.04
Outcome
5 Percentage of primary and/or secondary
operated patients, with severe
complications (CDC grade 3 or higher)
within 30 days after surgery.
305 10,355 2.92 332 11,586 2.87
6 Percentage of primary and/or secondary
operated patients, with a postoperative
intervention within 30 days after
surgery.
294 10,355 2.84 316 11,586 2.73
7 Percentage of primary operated patients,
with more than 50% excess weight loss
(%EWL) in the first year after primary
surgery.
– – – 5346 6433 83.1
8 Percentage of primary operated patients,
with more than 20% total weight loss
(%TWL) in the first year after primary
surgery.
– – – 5538 6433 86.1
N numerator,D denominator, CDC Clavien-Dindo Classification of Surgical Complications, BMI body mass index
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Analysis
Differences between patient and treatment characteristics were
described using frequency tables. Categorical variables were
compared using the chi-square trend test. Results of quality
indicators and outcomes were presented concerning patients
who had primary and/or secondary surgery from January 1,
2015, until December 31, 2016. Differences in quality indica-
tor results over time were calculated with the chi-square trend
test.
R version 3.4.1 is used for statistical analysis in combina-
tion with the BCompanion to Applied Regression^-package
(car 2.1–5) and BA Grammar of Data Manipulation^-package
(dplyr 0.7.2).
Results
Between 2015 and 2016, a total of 21,634 unique patients
were registered in the DATO, with a total record count of
21,941. Of these, 18,784 (85.6%) operations were primary
procedures. The mean age was 43.8 years (± 11.2 SD), with
a median of 44 years. The mean BMI was 43.3 kg/m2 (± 5.4
SD) and median of 42.3 kg/m2.
The largest group of procedures involved patients with a
Roux-en-Y gastric bypass (RYGB) (72.4%; n = 15,889),
followed by gastric sleeve (GS) (17.7%; n = 3885), one anas-
tomosis gastric bypass (OAGB) (5.9%; n = 1298) and other
procedures (4.0%; n = 869).
Structure Indicator
All 18 bariatric centers met the quality indicator regarding a
minimum of 100 bariatric procedures per individual hospital,
with a range of 171 to 1153 procedures.
Process Indicators
The process indicator defined as completeness of the regis-
tered patient, which means all mandatory variables were reg-
istered in DATO to calculate the indicators, revealed a 92.1%
(n = 9534) completeness in 2015, which increased in 2016 to
94.3% (n = 11,586).
In 2015, 95.6% (n = 8371) of the cases met the require-
ments for bariatric surgery, which increased in 2016 to
96.0% (n = 9625). In 0.8% (n = 169) of all registered cases,
the BMI were unknown, 2.0% (n = 431) had an unknown
presence of any comorbidity, and in 0.02% (n = 5), the age
could not be calculated.
In 2016, the lost to-follow-up percentage was 2.04% (n =
131) of the 6433 primary bariatric procedures performed from
January to October 2015.
Outcome Indicators
The first measured outcome indicator was mortality, also mea-
sured as CDC grade 5, within 30 days after surgery or during
the same hospital stay. In 2015, 10 patients (0.1%) died after
surgery; whereas, 6 patients (0.05%) died in 2016.
The postoperative complicated course within 30 days after
surgery or during the same hospital stay was measured by
CDC grade 3 or higher. Grade 4 was described as life-
threatening complications requiring intensive care admission,
which occurred 65 times (0.6%) in 2015 and 91 times (0.8%)
in 2016. Requiring surgical, endoscopic, or radiological inter-
vention (grade 3) had to take place 230 times (2.2%) in 2015
and 235 times (2.0%) in 2016. Added together, any compli-
cation during admission occurred in 3.0% (n = 305) of the
cases in 2015 and 2.8% (n = 322) in 2016.
In 2016, 83.1% (n = 5346) of the operated patients from
January 2015 till October 2015 had reached more than 50%
EWL after primary surgery. The group with the highest per-
centage of > 50% EWL was OAGB (86.8%; n = 275),
Fig. 3 Percentage of primary
operated patients in 2016,
registered in the Dutch Audit for
Treatment of Obesity (DATO),
with severe complications
(Clavien-Dindo grade 3 or higher)
within 30 days after surgery, as
reported per hospital
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followed by RYGB (85.0%; n = 4218), GS (72.3%; n = 825),
and other procedures (34.5%; n = 29).
From January 2015 till October 2015, 86.1% (n = 5538) of
the operated patients succeeded more than 20% Total Weight
Loss (TWL) after primary surgery at the first-year follow-up
in 2016. The highest percentage of >20% TWL, was mea-
sured at OAGB (90.2%; n = 286), followed by RYGB
(87.2%; n = 4325), GS (78.8%; n = 899) and other procedures
(34.5%; n = 29).
Discussion
This manuscript provided an extensive and complete over-
view of the aforementioned process in establishing a nation-
wide registry in the Netherlands, with the Dutch Audit of
Treatment of Obesity (DATO) as a result.
DATO was mandatory for all bariatric centers, and there-
fore it was required to register all bariatric procedures. This
was a requirement of the insurance companies to carry out
bariatric surgery. DATO provided a nationwide transparent
overview and results of bariatric procedures. By identifying
positive outliers based on benchmarked indicators, DATO can
provide healthcare professionals with actable information to
improve their care and patients with valid information to
choose a hospital of their preference.
Clinical Auditing
The cornerstone of effective auditing is to provide high quality
standards for entering data in an online accessible tool, using
uniform international definitions, and producing interactive
feedback charts for individual healthcare centers to improve
care where necessary. Only when all surgeons and healthcare
centers are participating in the registry, valid conclusion can
be drawn from the provided benchmark information [11, 28,
29]. In the first years of registration, DATO succeed in the
mission of high quality data, national coverage, and providing
useful benchmark information for the individual clinic [30].
Complicated Course
Bariatric procedures were considered relatively safe, regard-
ing to other surgical interventions, where mortality and mor-
bidity were considered acceptable [1, 4, 31, 32]. With 16
deaths out of 21,634 unique patients in the past 2 years, bar-
iatric surgery in the Netherlands can be considered relatively
safe. A severe complication during admission was character-
ized by CDC grade 3 or higher. This occurs in 2.9% of pa-
tients. It is remarkable that in about 0.8% of cases, the
Bcomplication^ involved a diagnostic laparoscopy. In bariatric
surgery, however, this is considered a valuable diagnostic tool.
When compared to international literature, the number of se-
rious complications was significantly lower in DATO [4, 31].
Limitations
The DATO dataset contains a large set of data points to cover a
wide variety of bariatric treatment characteristics. This is as-
sociated with a substantial administrative burden, because bar-
iatric surgeons are responsible for providing their own surgical
and follow-up data. Nevertheless, the dataset is limited and
needs careful evaluation on a yearly base to prevent adverse
grow. Technological innovation will contribute to higher data
quality and smoother registration processes. In addition, it will
be possible to get more useful information from other sources
of registration to improve patient care.
Because the data provided by hospitals is self-reported, data
fraud is a possible adverse effect. Therefore, an independent third-
party visits bariatric centers and produces discrepancy reports to
validate the data of individual centers. Bariatric centers receive the
report and use it to improve the quality of data entry by their
bariatric surgeons or trained personnel. A third limitation concerns
the content of the DATO. From the start, the audit aimed to work
together with paramedics and post-bariatric care providers.
However, there are some privacy issues, and therefore it has been
decided to focus primarily on bariatric surgery for now.
Future Perspectives
DATO was designed with the idea that registering clinical
information is not sufficient to give a total view of the out-
comes of the treatment of bariatric surgery. It was immediately
decided by the scientific bureau to measure PROs as well.
Because these two instruments could technically not directly
be linked, the PROs are measured in a separate database. A
cross-matching with the clinical database is planned. For fur-
ther improvement, initiatives are currently being undertaken
for comparison with other European registries.
Conclusion
The Dutch Audit for Treatment of Obesity has become rapidly
a mature registry. The well-organized structure of the national
audit, the cooperation with DICA, and governmental funding
are essential. However, most importantly were the bariatric
surgeons themselves: unconditional nationwide participation
including very high response for PROMs. The authors believe
reporting the results from the registry has already contributed
to more knowledge and acceptance by other health care pro-
viders, improved quality as each center got feedback about its
performance, and improved discussion with health organiza-
tions such as insurance companies about quality and indica-
tors. This provides enthusiasm for the future.
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